Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Negro

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|September 16, 2014
Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headachesMarzia Lecchi, Lidia D'Alonzo, Andrea Negro, et al.
Therapeutics and Clinical Risk Management|May 3, 2019
Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapyChiara Lupi, Simona Guerzoni, Andrea Negro, et al.
Expert Opinion on Investigational Drugs|April 20, 2012
CGRP receptor antagonists: an expanding drug class for acute migraine?Andrea Negro, Luana Lionetto, Maurizio Simmaco, et al.
Expert Review of Neurotherapeutics|October 9, 2012
Deciphering the task of N-acetyl aspartate in migraineLuana Lionetto, Matilde Capi, Gabriele Vignaroli, et al.
The Journal of Headache and Pain|September 28, 2012
Ictal epileptic headache: an old story with courses and appealsPasquale Parisi, Pasquale Striano, Andrea Negro, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 5, 2019
Pharmacokinetics and pharmacodynamics of new acute treatments for migraineChiara Lupi, Silvia Benemei, Simona Guerzoni, et al.
Expert Review of Neurotherapeutics|December 10, 2020
Evaluating and managing severe headache in the emergency departmentMichelangelo Luciani, Andrea Negro, Valerio Spuntarelli, et al.
Expert Opinion on Pharmacotherapy|June 19, 2014
Sodium channel antagonists for the treatment of migraineLorenza Chiossi, Andrea Negro, Matilde Capi, et al.
Expert Opinion on Biological Therapy|May 19, 2021
Eptinezumab for the treatment of migraineValerio Spuntarelli, Andrea Negro, Michelangelo Luciani, et al.
Springerplus|January 12, 2016
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective studyAndrea Negro, Martina Curto, Luana Lionetto, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Expert Opinion on Drug Metabolism & Toxicology|September 16, 2014
Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headachesMarzia Lecchi, Lidia D'Alonzo, Andrea Negro, et al.
Therapeutics and Clinical Risk Management|May 3, 2019
Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapyChiara Lupi, Simona Guerzoni, Andrea Negro, et al.
Expert Opinion on Investigational Drugs|April 20, 2012
CGRP receptor antagonists: an expanding drug class for acute migraine?Andrea Negro, Luana Lionetto, Maurizio Simmaco, et al.
Expert Review of Neurotherapeutics|October 9, 2012
Deciphering the task of N-acetyl aspartate in migraineLuana Lionetto, Matilde Capi, Gabriele Vignaroli, et al.
The Journal of Headache and Pain|September 28, 2012
Ictal epileptic headache: an old story with courses and appealsPasquale Parisi, Pasquale Striano, Andrea Negro, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 5, 2019
Pharmacokinetics and pharmacodynamics of new acute treatments for migraineChiara Lupi, Silvia Benemei, Simona Guerzoni, et al.
Expert Review of Neurotherapeutics|December 10, 2020
Evaluating and managing severe headache in the emergency departmentMichelangelo Luciani, Andrea Negro, Valerio Spuntarelli, et al.
Expert Opinion on Pharmacotherapy|June 19, 2014
Sodium channel antagonists for the treatment of migraineLorenza Chiossi, Andrea Negro, Matilde Capi, et al.
Expert Opinion on Biological Therapy|May 19, 2021
Eptinezumab for the treatment of migraineValerio Spuntarelli, Andrea Negro, Michelangelo Luciani, et al.
Springerplus|January 12, 2016
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective studyAndrea Negro, Martina Curto, Luana Lionetto, et al.
Pageof 8